Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Country / region: United Kingdom Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20055
20061
20072
20093
20102
20114
20123
20137
20147
20153
20164
20176
20187
20192
20206
20213
20223
20238
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting15
Unknown status12
Terminated10
Active, not recruiting4
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Amgen7
University College, London7
Kiadis Pharma5
Bristol-Myers Squibb4
University of Birmingham4
AbbVie3
AstraZeneca3
Princess Maxima Center for Pediatric Oncology3
Amgen Research (Munich) GmbH2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma96
Leukemia, Myeloid, Acute28
Leukemia21
Myelodysplastic Syndromes16
Lymphoma, Non-Hodgkin15
Burkitt Lymphoma14
Recurrence13
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12
Lymphoma11
Hodgkin Disease10

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.